China approves three Gilead remdesivir patents for COVID-19 treatment

US-based Gilead Sciences has been granted three Chinese patents connected to possible COVID-19 treatment remdesivir, reported He Zhimin, the deputy director of China’s National Intellectual Property Administration (CNIPA).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

China unveils new drug patenting rules

11 February 2021 China has introduced new measures to enforce a patent linkage system and proposed draft rules on how a patent owner can challenge the approval of a drug.

Big Pharma

Novavax partners with Takeda to deliver COVID-19 vaccine in Japan

10 August 2020 US biotechnology company Novavax has signed a deal with Takeda Pharmaceuticals to develop, manufacture and market a COVID-19 vaccine in Japan, it was announced on Friday, August 7.

Asia

Rouse and Codex launch new China partnership

4 June 2020 IP firm Rouse will collaborate with life sciences service provider Codex to support companies looking to enter the Chinese market.

More on this story

Big Pharma

China unveils new drug patenting rules

11 February 2021 China has introduced new measures to enforce a patent linkage system and proposed draft rules on how a patent owner can challenge the approval of a drug.

Big Pharma

Novavax partners with Takeda to deliver COVID-19 vaccine in Japan

10 August 2020 US biotechnology company Novavax has signed a deal with Takeda Pharmaceuticals to develop, manufacture and market a COVID-19 vaccine in Japan, it was announced on Friday, August 7.

Asia

Rouse and Codex launch new China partnership

4 June 2020 IP firm Rouse will collaborate with life sciences service provider Codex to support companies looking to enter the Chinese market.

More on this story

Big Pharma

China unveils new drug patenting rules

11 February 2021 China has introduced new measures to enforce a patent linkage system and proposed draft rules on how a patent owner can challenge the approval of a drug.

Big Pharma

Novavax partners with Takeda to deliver COVID-19 vaccine in Japan

10 August 2020 US biotechnology company Novavax has signed a deal with Takeda Pharmaceuticals to develop, manufacture and market a COVID-19 vaccine in Japan, it was announced on Friday, August 7.

Asia

Rouse and Codex launch new China partnership

4 June 2020 IP firm Rouse will collaborate with life sciences service provider Codex to support companies looking to enter the Chinese market.